Results 281 to 290 of about 953,056 (326)

cDC1 Subtype‐Specific In Vivo Targeting of Liposomes

Advanced Science, EarlyView.
Dendritic cells, particularly the cDC1 subtype, offer a promising target for drug delivery via liposomes due to their pivotal role in immune regulation, allowing for amplified therapeutic responses. Herein, we show an integration of physicochemical characterization and cell experiments to achieve effective in vivo cDC1 targeting through anti‐CLEC9A ...
Maximilian Schaaf, Michael Fichter, Lin Jian, Felicia Schön, Carina Jung, Paul Schneider, Kai Speth, Ana Mateos‐Maroto, Volker Mailänder, Kaloian Koynov, Svenja Morsbach, Katharina Landfester   +11 more
wiley   +1 more source

An IQ Consortium Perspective on the FDA Guidance for Assessment of Pharmacokinetics in Participants With Impaired Renal Function. [PDF]

Clin Pharmacol Ther
Jin Y, Sharma A, Ahmed MA, Cheeti S, Ou Y, Devineni D, Chen Y, Kanodia JS, Abouelhassan Y, Noormohamed N, Zhou J, Marroum P, Sahasrabudhe V, Younis IR.   +13 more
europepmc   +1 more source

Compliance With FDA iCGM Special Controls is Dependent on Study Design and Procedures

Manuel Eichenlaub, Delia Waldenmaier, Stefan Pleus, Cornelia Haug, Derek Brandt, Guido Freckmann   +5 more
openalex   +2 more sources

Automating Individualized Notification of Drug Recalls to Patients: Complex Challenges and Qualitative Evaluation. [PDF]

JMIRx Med
Gadgil M, Pavlakos R, Carini S, Turner B, Elder I, Hess W, Houle L, Huff L, Johanson E, Ramos-Izquierdo C, Liang D, Ogonowski P, Phipps J, Peryea T, Sim I.   +14 more
europepmc   +1 more source

FDA medical device regulation and informed consent.

, 1999
Jordan Smith, M E Jensen, Jocelyne Dion
openalex   +1 more source

Advances in orphan drug development for alpha-1 antitrypsin deficiency: a 2025 update from the FDA and EMA. [PDF]

Ther Adv Respir Dis
Höger P, Ries M, Olivares Rivera A, Ersöz H, Buschulte K, Fähndrich S, Kontogianni K, Herth F, Trudzinski FC.   +8 more
europepmc   +1 more source

21st Century Citizen Pharma: The FDA & Patient-Focused Product Development

, 2018
Jordan Paradise
openalex   +1 more source

Comparison of two tablet splitting methods on mass loss and weight uniformity by nurses in North West Ethiopia. [PDF]

Sci Rep
Ashagrie T, Habteyes AT, Mekonen FT.
europepmc   +1 more source

The real-world safety of lacosamide and perampanel in children: a disproportionality analysis of the FDA Adverse Event Reporting System

Yani Tan, Cuilin Li, Yi Qin, Xin Liu, Yuping Yang, Lian Zheng, Long Wei, Li Huang   +7 more
openalex   +1 more source

Beyond discovery: are we understanding PET tracers as fast as we invent them? a critical review. [PDF]

EJNMMI Res
Ibrahim EA.
europepmc   +1 more source